Director, Heart Failure, Transplant and Mechanical Circulatory Support
Nir Uriel, MD, is a leader in the field of heart failure, mechanical circulatory support and heart transplantation. He specializes in caring for patients who require mechanical circulatory support, including ventricular assist devices (VADs).
Dr. Uriel's research focuses on advanced heart failure physiology, heart transplant and mechanical circulatory support. Dr Uriel specialized and reported physiological changes and developed treatment algorithms for patients supported with Mechanical Circulatory Support that are being used worldwide. These findings were published in the Journal of American College of Cardiology. He has a strong interest in high-risk transplant populations, including HIV-positive patients and patients who have received mediastinal radiation due to tumors or prior transplants. Through his research, Dr. Uriel has improved treatment protocols and patient care for these high-risk groups.
An accomplished author, Dr. Uriel has published more than 80 original, peer-reviewed articles. In addition, he serves as a reviewer for several scientific journals, including American Journal of Transplantation, Journal of American College of Cardiology and Journal of Heart and Lung Transplantation.
The University of Chicago Medicine
5841 S. Maryland Avenue
Chicago, IL 60637
2004
Internal Medicine (Israel)
Cardiology (Israel)
Ben Gurion University of the Negev
Assaf Harofeh Hospital
Assaf Harofeh Hospital
New York Presbyterian Hospital/Columbia University Medical Center
MSc, Columbia University Mailman School of Public Health (POR - Biostatistics)
American Heart Association
International Society of Heart and Lung Transplantation
Israel Cardiology Society
Israel Medical Association
English
Hebrew
(773) 702-9396
(773) 834-1764
Nir Uriel, MD
The University of Chicago Medicine
5841 S. Maryland Avenue, MC 2016
Chicago, IL 60637
Related Videos
End Stage Systolic Heart Failure: When the End May Not Be the End
Dr. Uriel, MD, discusses updates, regimens, and treatment for End Stage Systolic Heart Failure.